Header cover image

Tunisian (TUNINDEX) Pharma Industry Analysis

UpdatedApr 24, 2024
DataAggregated Company Financials
Companies2
  • 7D1.6%
  • 3M4.3%
  • 1Y-2.7%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 1.3%, driven by Unité de Fabrication des Médicaments declining 1.5%. As for the longer term, the industry's performance has been flat for the past year. Looking forward, earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Tunisian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 24 Apr 2024د.ت240.7mد.ت115.1mد.ت13.1m17.8x18.3x2.1x
Fri, 22 Mar 2024د.ت239.7mد.ت115.1mد.ت13.1m17.8x18.3x2.1x
Sun, 18 Feb 2024د.ت235.2mد.ت115.1mد.ت13.1m17.4x17.9x2x
Tue, 16 Jan 2024د.ت362.7mد.ت223.6mد.ت13.6m136.5x26.6x1.6x
Thu, 14 Dec 2023د.ت365.6mد.ت223.6mد.ت13.6m136.5x26.8x1.6x
Sat, 11 Nov 2023د.ت388.3mد.ت223.6mد.ت13.6m137.2x28.5x1.7x
Mon, 09 Oct 2023د.ت392.2mد.ت223.6mد.ت13.6m137.4x28.8x1.8x
Wed, 06 Sep 2023د.ت383.2mد.ت204.8mد.ت8.3m143.5x46x1.9x
Fri, 04 Aug 2023د.ت390.1mد.ت204.8mد.ت8.3m143.9x46.8x1.9x
Sun, 02 Jul 2023د.ت390.2mد.ت204.8mد.ت8.3m143.9x46.8x1.9x
Tue, 30 May 2023د.ت369.3mد.ت205.0mد.ت8.3m142.7x44.3x1.8x
Thu, 27 Apr 2023د.ت374.1mد.ت194.8mد.ت5.6m151.4x67x1.9x
Sat, 25 Mar 2023د.ت373.8mد.ت194.8mد.ت5.6m151.3x67x1.9x
Mon, 20 Feb 2023د.ت364.6mد.ت194.8mد.ت5.6m150.1x65.3x1.9x
Wed, 18 Jan 2023د.ت355.3mد.ت194.8mد.ت5.6m149.4x63.7x1.8x
Fri, 16 Dec 2022د.ت362.7mد.ت194.8mد.ت5.6m150.1x65x1.9x
Sun, 13 Nov 2022د.ت370.7mد.ت194.8mد.ت5.6m150.9x66.4x1.9x
Tue, 11 Oct 2022د.ت372.6mد.ت194.8mد.ت5.6m151.2x66.8x1.9x
Thu, 08 Sep 2022د.ت384.5mد.ت192.3mد.ت9.2m142.2x41.8x2x
Sat, 06 Aug 2022د.ت366.1mد.ت179.5mد.ت10.2m54.8x35.8x2x
Mon, 04 Jul 2022د.ت357.8mد.ت179.5mد.ت10.2m52.1x35x2x
Wed, 01 Jun 2022د.ت332.4mد.ت181.0mد.ت7.8m51x42.7x1.8x
Fri, 29 Apr 2022د.ت346.2mد.ت173.5mد.ت4.0m36.8x85.6x2x
Sun, 27 Mar 2022د.ت351.6mد.ت173.5mد.ت4.0m38.3x87x2x
Tue, 22 Feb 2022د.ت359.9mد.ت173.5mد.ت4.0m38.5x89x2.1x
Thu, 20 Jan 2022د.ت353.4mد.ت173.5mد.ت4.0m38x87.4x2x
Sat, 18 Dec 2021د.ت353.1mد.ت173.5mد.ت4.0m38.8x87.3x2x
Mon, 15 Nov 2021د.ت362.8mد.ت173.5mد.ت4.0m40.8x89.7x2.1x
Wed, 13 Oct 2021د.ت350.6mد.ت173.5mد.ت4.0m38.2x86.7x2x
Fri, 10 Sep 2021د.ت329.0mد.ت207.6m-د.ت11,805,759.0031.4x-27.9x1.6x
Sun, 08 Aug 2021د.ت331.6mد.ت178.5mد.ت4.8m32x69.7x1.9x
Sat, 01 May 2021د.ت340.5mد.ت183.6mد.ت6.7m34.3x51x1.9x
Price to Earnings Ratio

51x


Total Market Cap: د.ت340.5mTotal Earnings: د.ت6.7mTotal Revenue: د.ت183.6mTotal Market Cap vs Earnings and Revenue0%0%0%
Tunisian Pharma Industry Price to Earnings3Y Average 55.2x202220232024
Current Industry PE
    There are only 2 companies in the Tunisian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 25% per year over the last three years.
  • Meanwhile revenues for these companies have declined 14% per year.
  • This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.

Industry Comparison

How does Tunisian Pharma compare with similar industries?

TN Market-0.47%
Healthcare1.62%
Pharma1.62%
Pharma1.62%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UMED Unité de Fabrication des Médicamentsد.ت7.301.7%
+د.ت3.8m		-2.5%PE17.8x
SIPHA Société des Industries Pharmaceutiques de Tunisie -د.ت3.924.5%
+د.ت306.0k		12.0%n/a
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

UMED

د.ت7.30

Unité de Fabrication des Médicaments

7D

1.7%

1Y

-2.5%

SIPHA

د.ت3.92

Société des Industries Pharmaceutiques de Tunisie -

7D

4.5%

1Y

12.0%